文献速递心脑血管急症重症综合管理与镇静镇痛

七氟烷镇静较丙泊酚改善心脏骤停后基于脑电图良好预后的预测

EEG based predictions of good outcome after cardiac arrest improve with sevoflurane sedation, as compared with propofol.
PubMed 文献 · Resuscitation · 2025-10-15
一句话结论心脏骤停后昏迷患者,七氟烷镇静在12小时脑电图上预测良好预后的敏感性高于丙泊酚,且不显著损失特异性。

这项回顾性队列研究纳入荷兰两家教学医院重症监护室收治的412例心脏骤停后复苏的成年昏迷患者,其中51例仅用七氟烷镇静并降温至36°C,361例用丙泊酚镇静并降温至33°C。分析骤停后12小时和24小时脑电图模式(视觉和定量分类为有利、不利或其他)与6个月结局(脑功能分级1-2为良好,3-5为不良)。12小时脑电图预测良好预后时,七氟烷组敏感性0.89(95%CI 0.62-1.00),丙泊酚组0.42(95%CI 0.34-0.50),特异性分别为0.71(95%CI 0.44-0.91)和0.88(95%CI 0.81-0.92),无显著特异性损失;24小时脑电图预测良好预后及12、24小时预测不良预后时两组敏感性和特异性无显著差异。结论认为七氟烷镇静与12小时后较少出现不连续脑电图相关,有助于更早可靠预测良好预后,但两组的温度管理差异可能带来偏倚。

要点

  • 心脏骤停后12小时脑电图预测良好预后:七氟烷镇静组敏感性0.89(95%CI 0.62-1.00),丙泊酚组0.42(95%CI 0.34-0.50)。
  • 12小时脑电图预测良好预后的特异性:七氟烷组0.71(95%CI 0.44-0.91),丙泊酚组0.88(95%CI 0.81-0.92),无显著损失。
  • 24小时脑电图预测良好预后及12、24小时预测不良预后时,七氟烷与丙泊酚组的敏感性和特异性均无显著差异。
  • 七氟烷镇静与心脏骤停后12小时较少出现不连续脑电图相关,可能支持更早可靠地预测良好预后。
  • 该研究为非随机两中心队列,两组温度管理不同(36°C vs 33°C),不能排除潜在偏倚。

适用人群与场景

  • 荷兰两家大型教学医院重症监护室收治的年龄≥18岁心脏骤停后复苏的昏迷患者。
  • 一家医院所有心脏骤停患者仅用七氟烷镇静并降温至36°C,另一家医院用丙泊酚镇静并降温至33°C。

诊断标准与关键阈值

  • 脑电图模式于心脏骤停后12小时和24小时进行视觉和定量分析,分类为有利、不利或其他模式。
  • 定量参数包括背景连续性指数、爆发-抑制振幅比和α-δ比。
  • 6个月结局用脑功能分级定义:1或2级为良好,3、4或5级为不良。

研究设计与关键结果

  • 回顾性队列研究纳入412例患者,七氟烷镇静51例,丙泊酚镇静361例。
  • 12小时脑电图预测良好预后:七氟烷组敏感性0.89(95%CI 0.62-1.00),丙泊酚组0.42(95%CI 0.34-0.50)。
  • 12小时脑电图预测良好预后的特异性:七氟烷组0.71(95%CI 0.44-0.91),丙泊酚组0.88(95%CI 0.81-0.92),无显著损失。
  • 24小时脑电图预测良好预后以及12、24小时预测不良预后时,两组敏感性和特异性无显著差异。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文报告为非随机两中心队列研究,温度管理差异可能带来潜在偏倚,不能排除。

对床旁实践的改变

  • 作者认为,七氟烷镇静与心脏骤停后12小时较少出现不连续脑电图相关,有助于更早和可靠地预测良好预后。
  • 作者指出,七氟烷和丙泊酚对不良预后的预测均可靠。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: We investigated the prognostic value of the early electroencephalogram (EEG) in comatose patients after cardiac arrest, sedated with sevoflurane, as compared to those sedated with propofol.

METHODS: This retrospective cohort study included all resuscitated patients aged ≥18 after cardiac arrest (CA) admitted to the intensive care unit of two large Dutch teaching hospitals. In one hospital all CA patients were sedated with sevoflurane only and cooled to 36 °C, while in the other hospital the patients were sedated with propofol and cooled to 33 °C. EEG patterns at 12 and 24 h after CA were analyzed visually and quantitatively and classified as favorable, unfavorable or other EEG patterns. Quantitative parameters including background continuity index, burst-suppression amplitude ratio, and alpha-delta ratio were compared between groups of sedation. Outcome at 6 months was defined as good (Cerebral Performance Category 1 or 2) or poor (Cerebral Performance Category 3, 4 or 5).

RESULTS: We included 412 patients of whom 51 sevoflurane-sedated and 361 propofol-sedated. Predicting good outcome at 12 h after CA, we found a higher sensitivity for those sedated with sevoflurane (0.89, 95 %-CI 0.62-1.00), as compared with those sedated with propofol (0.42, 95 %-CI 0.34-0.50), without significant loss of specificity (0.71, 95 %-CI 0.44-0.91 and 0.88, 95 %-CI 0.81-0.92 respectively). No significant differences in sensitivity and specificity were found between sedation with sevoflurane and propofol for predicting good outcome using the EEG at 24 h after CA. For prediction of poor outcome at 12 and 24 h after CA, no significant differences were found between patients sedated with sevoflurane and propofol regarding sensitivity and specificity.

CONCLUSION: In this non-randomised two-centre cohort study, sevoflurane sedation was associated with less frequent discontinuous EEG 12 h after cardiac arrest, enabling earlier and reliable prediction of good outcome. Prediction of poor outcome was reliable with both sevoflurane and propofol. However, potential bias due to differences in temperature management cannot be excluded.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Fleuren-Janssen MWH, Ruijter BJ, le Noble JLML, et al. EEG based predictions of good outcome after cardiac arrest improve with sevoflurane sedation, as compared with propofol. Resuscitation. 2025. PMID: 41106585. doi:10.1016/j.resuscitation.2025.110862

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。